Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...
Stay updated with breaking news from Regt Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...
Gilead has tagged along on Kyverna Therapeutics’ journey as a startup since the beginning, and now the Big Pharma has helped stock up the cell therapy biotech in an $85 million financing round to prepare for a launch into the clinic this year.
Investegate announcements from RTW Venture Fund Ltd, New Investment in Kyverna
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!